Comparison of extracellular phospholipase activities in clinical and environmental Aspergillus fumigatus isolates

Medical Mycology

Volumn 42, Issue 1, 2004, Pages 81-86

  Birch, Mike ^a,b   Denning, David W ^a   Robson, Geoffrey D ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b F2G LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LYSOPHOSPHOLIPASE; PHOSPHOLIPASE; PHOSPHOLIPASE A; PHOSPHOLIPASE C;

ARTICLE; ASPERGILLUS FUMIGATUS; COMPARATIVE STUDY; CONTROLLED STUDY; DIFFUSION; ENVIRONMENT; ENZYME ACTIVITY; ENZYME SYNTHESIS; EXTRACELLULAR SPACE; FUNGUS ISOLATION; NONHUMAN; PATHOGENICITY;

ASPERGILLUS FUMIGATUS; HUMANS; LYSOPHOSPHOLIPASE; MICROBIAL SENSITIVITY TESTS; PHOSPHOLIPASE C; PHOSPHOLIPIDS;

ASPERGILLUS; ASPERGILLUS FUMIGATUS; FUNGI;

EID: 0842264837     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/13693780310001610029     Document Type: Article

References (51)

1. Brookman JL, Denning DW. Molecular genetics in Aspergillus fumigatus. Curr Opin Microbiol 2000; 3: 469-474.
2. Groll AH, Shah PM, Mentzel C, Schneider M, Just Nuebling G, Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996; 33: 23-32.
3. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999; 12: 310-350.
4. Latge JP. The pathobiology of Aspergillus fumigatus. Trends Microbiol 2001; 9: 382-389.
5. Tomee JFC, Kauffman HF. Putative virulence factors of Aspergillus fumigatus. Clin Exp Allergy 2000; 30: 476-484.
6. Bouchara JP, Bouali A, Tronchin G, Robert R, Chabasse D, Senet JM. Binding of fibrinogen to the pathogenic Aspergillus species. J Med Vet Mycol 1988; 26: 327-334.
7. Coulot P, Bouchara JP, Renier G, Annaix V, Planchenault C, Tronchin G, Chabasse D. Specific interaction of Aspergillus fumigatus with fibrinogen and its role in cell adhesion. Infect Immun 1994; 62: 2169-2177.
8. Penalver MC, O'Connor JE, Martinez JP, Gil ML. Binding of human fibronectin to Aspergillus fumigatus conidia. Infect Immun 1996; 64: 1146-1153.
9. Tronchin G, Esnault K, Renier G, Filmon R, Chabasse D, Bouchara JP. Expression and identification of a laminin-binding protein in Aspergillus fumigatus conidia. Infect Immun 1997; 65: 9-15.
10. Wasylnka JA, Moore MM. Adhesion of Aspergillus species to extracellular matrix proteins: Evidence for involvement of negatively charged carbohydrates on the conidial surface. Infect Immun 2000; 68: 3377-3384.
11. Arruda L, Mann B, Chapman M. Selective expression of a major allergen and cytotoxin, Asp f1, in Aspergillus fumigatus. Implications for the immunopathogenesis of Aspergillus related disease. J Immun 1992; 149: 3354-3359.
12. Bauer J, Gareis M, Bott A, Gedik B. Isolation of a mycotoxin (gliotoxin) from a bovine udder infected with Aspergillus fumigatus. J Med Vet Mycol 1989; 27: 45-50.
13. Madan T, Arora N, Sarma PU. Identification and evaluation of a major cytotoxin of A. fumigatus. Mol Cell Biochem 1997; 167: 89-97.
14. Müllbacher A, Waring P, Eichner RD. Identification of an agent in cultures of Aspergillus fumigatus displaying anti-phagocytic and immunomodulating activity in vitro. J Gen Microbiol 1985; 131: 1251-1258.
15. Yamada A, Kataoka T, Nagai K. The fungal metabolite gliotoxin: Immunosuppressive activity on CTL-mediated cytotoxicity. Immunol Lett 2000; 71: 27-32.
16. Arruda LK, Platts-Mills TA, Fox JW, Chapman MD. Aspergillus fumigatus allergen I, a major IgE-binding protein is a member of the mitogillin family of cytotoxins. J Exp Med 172: 1529-1532.
17. Eichner RD, Tiwari-Palni U, Waring P, Müllbacher A. Detection of the immunomodulating agent gliotoxin in experimental aspergillosis. In: Torres-Rodriguez JM (ed.). Proceedings of the 10th Congress of ISHAM. Barcelona: J. R. Prous Science Publishing, 1988: 133-137.
18. Lamy B, Moutaouakil M, Latge JP, Davies J. Secretion of a potential virulence factor, a fungal ribonucleotoxin, during human aspergillosis infections. Mol Microbiol 1991; 5: 1811-1815.
19. Richard JL. Gliotoxin, a mycotoxin associated with cases of avian aspergillosis. J Nat Toxins 1997; 6: 11-18.
20. Paris S, Monod M, Diaquin M, Lamy B, Arruda LK, Punt PJ, Latge JP. A transformant of Aspergillus fumigatus deficient in the antigenic cytotoxin ASPFI. FEMS Microbiol Lett 1993; 111: 31-36.
21. Smith JM, Davies JE, Holden DW. Construction and pathogenicity of Aspergillus fumigatus mutants that do not produce the ribotoxin restrictocin. Mol Microbiol 1993; 9: 1071-1077.
22. Smith J, Tang C, Van-Noorden S, Holden D. The virulence of Aspergillus fumigatus double mutants lacking restrictocin and an alkaline protease in a low-dose model of invasive pulmonary aspergillosis. Infect Immun 1994; 62: 5247-5254.
23. Monod M, Paris S, Sanglard D, Jaton Ogay K, Bille J, Latge JP. Isolation and characterization of a secreted metalloprotease of Aspergillus fumigatus. Infect Immun 1993; 61: 4099-4104.
24. Moutaouakil M, Monod M, Prevost MC, Bouchara JP, Paris S, Latge JP. Identification of the 33-kDa alkaline protease of Aspergillus fumigatus in vitro and in vivo. J Med Microbiol 1993; 39: 393-399.
25. Reichard U, Monod M, Ruchel R. Molecular cloning and sequencing of the gene encoding an extracellular aspartic proteinase from Aspergillus fumigatus. FEMS Microbiol Lett 1995; 130: 69-74.
26. Jayton Ogay K, Paris S, Huerre M, Quadroni M, Falchetto R, Togni G, Latge JP, Monod M. Cloning and disruption of the gene encoding an extracellular metalloprotease of Aspergillus fumigatus. Mol Microbiol 1994; 14: 917-928.
27. Monod M, Paris S, Sarfati J, Jaton Ogay K, Ave P, Latge JP. Virulence of alkaline protease-deficient mutants of Aspergillus fumigatus. FEMS Microbiol Lett 1993; 106: 39-46.
28. Reichard U, Monod M, Odds F, Ruchel R. Virulence of an aspergillopepsin-deficient mutant of Aspergillus fumigatus and evidence for another aspartic proteinase linked to the fungal cell wall. J Med Vet Mycol 1997; 35: 189-196.
29. Tang CM, Cohen J, Krausz T, Vannoorden S, Holden DW. The alkaline protease of Aspergillus fumigatus is not a virulence determinant in two murine models of the invasive pulmonary aspergillosis. Infect Immun 1993; 61: 1650-1656.
30. Kauffman HF, Tomee JF, Van De Riet MA, Timmerman AJ, Borger P. Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J Allergy Clin Immunol 2000; 105: 1185-1193.
31. Tomee JF, Wierenga AT, Hiemstra PS, Kauffman HK. Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines. J Infect Dis 1997; 176: 300-303.
32. Schmiel DH, Miller VL. Bacterial phospholipases and pathogenesis. Microb Infect 1999; 1: 1103-1112.
33. Titball RW. Bacterial phospholipases. Soc Appl Bacteriol Symp Ser 1998; 27: 127s-137s.
34. Chen SCA, Muller M, Zhou JZ, Wright LC, Sorrell TC. Phospholipase activity in Cryptococcus neoformans: A new virulence factor? J Infect Dis 1997; 175: 414.
35. Ibrahim AS, Mirbod F, Filler SG, Banno Y, Cole GT, Kitajima Y, Edwards JE, Nozawa Y, Ghannoum MA. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun 1995; 63: 1993-1998.
36. Kothavade RJ, Panthaki MH. Evaluation of phospholipase activity of Candida albicans and its correlation with pathogenicity in mice. J Med Microbiol 1998; 47: 99-102.
37. Vidotto V, Leone R, Sinicco A, Ito-Kuwa S, Criseo G. Comparison of phospholipase production in Cryptococcus neoformans isolates from AIDS patients and bird droppings. Mycopathologia 1998; 142: 71-76.
38. Cox GM, McDade HC, Chen SCA, Tucker SC, Gottfredsson M, Wright LC, Sorrell TC, Leidich SD, Casadevall A, Ghannoum MA, Perfect JR. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol 2001; 39: 166-175.
39. Leidich SD, Ibrahim AS, Fu Y, Koul A, Jessup C, Vitullo J, Fonzi W, Mirbod F, Nakashima S, Nozawa Y, Ghannoum MA. Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans. J Biol Chem 1998; 273: 26078-26086.
40. Birch M, Robson G, Law D, Denning DW. Evidence of multiple extracellular phospholipase activities of Aspergillus fumigatus. Infect Immun 1996; 64: 751-755.
41. Chen SCA, Wright LC, Santangelo RT, Muller M, Moran VR, Kuchel PW, Sorrell TC. Identification of extracellular phospholipase B, lysophospholipase, and acyltransferase produced by Cryptococcus neoformans. Infect Immun 1997; 65: 405-411.
42. Ghannoum MA. Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 2000; 13: 122-143.
43. Mirbod F, Banno Y, Ghannoum MA, Ibrahim AS, Nakashima S, Kitajima Y, Cole GT, Nozawa Y. Purification and charaterization of lysophospholipase-transacylase (h-1pta) from a highly virulent strain in Candida albicans. Biochim Biophys Acta 1995; 1257: 181-188.
44. Vogel H. A convenient growth medium for Neurospora (Medium N). Microbial Genet Bull 1956; 13: 42-44.
45. Tseng TC, Bateman DF. A phosphatidase produced by Sclerotium rolfsii. Phytopathology 1969; 59: 359-363.
46. Cho W, Kezdy J. Chromogenic substrates and assay of phospholipase A2. In: Dennis E (ed.). Methods in Enzymology, vol. 197. London: Academic Press, 1991: 75-79.
47. Watanabe I, Koishi R, Yao Y, Tsuji T, Serizawa N. Molecular cloning and expression of the gene encoding a phospholipase A1 from Aspergillus oryzae. Biosci Biotechnol Biochem 1999; 63: 820-826.
48. Titball RW. Bacterial phospholipases C. Microbiol Rev 1993; 57: 347-366.
49. Morgenroth K. The Surfactant System of the Lungs: Morphology and Clinical Significance. Berlin: W. de Gruyter, 1988.
50. Hoffman AG, Lawrence MG, Ognibene FP, Suffredini AF, Lipschik GY. Reduction of pulmonary surfactant in patients with human-immunodeficiency-virus infection and Pneumocystis carnii pneumonia. Chest 1992; 102: 1730-1736.
51. Saxena S, Madan T, Shah A, Muralidhar K, Sarma PU. Association of polymorphisms in the collagen region of SP-A2 with increased levels of total IgE antibodies and eosinophilia in patients with allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2003; 111: 1001-1007.